Kyunghee Burkitt, Ph.D.
Affiliations: | 2007 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Public Health, Molecular BiologyGoogle:
"Kyunghee Burkitt"Mean distance: (not calculated yet)
Cross-listing: PHTree
Parents
Sign in to add mentor| Rudy J. Richardson | grad student | 2007 | University of Michigan | |
| (Role of the Fanconi anemia pathway in head and neck cancers.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nigam N, Bernard B, Sevilla S, et al. (2023) SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck. Cell Reports. 42: 112823 |
| Bernard B, Burkitt K, Robbins Y, et al. (2020) Abstract 3651: Deciphering immunomodulatory roles of the SMYD3 methyltransferase in HPV-negative head and neck squamous cell carcinoma Cancer Research. 80: 3651-3651 |
| Burkitt K, Chun SY, Dang DT, et al. (2009) Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatment. Molecular Cancer Therapeutics. 8: 1148-56 |
| Dang DT, Chun SY, Burkitt K, et al. (2008) Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition. Cancer Research. 68: 1872-80 |
| Burkitt K, Ljungman M. (2008) Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin. Molecular Cancer. 7: 24 |
| Burkitt K, Chun S, Lynch JP, et al. (2008) 144 CDx2 Promotes Tumor Pericyte Content and Vascular Function in Human Colon Cancer Xenografts Gastroenterology. 134 |
| Burkitt K, Ljungman M. (2007) Compromised Fanconi anemia response due to BRCA1 deficiency in cisplatin-sensitive head and neck cancer cell lines. Cancer Letters. 253: 131-7 |